Soluble ST2 and CD163 as Potential Biomarkers to Differentiate Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

The differentiation of primary hemophagocytic lymphohistiocytosis (pHLH) and macrophage activation syndrome (MAS) poses a challenge to hematologists. The aim of this study was (1) to compare the levels of soluble ST2 (sST2), sCD163, IFN-γ, IL-10, IL-18, TNF-α and Serum soluble interleukin-2 receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Zhuo, Wang, Yini, Wang, Jingshi, Zhang, Jia, Wang, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328040/
https://www.ncbi.nlm.nih.gov/pubmed/30671214
http://dx.doi.org/10.4084/MJHID.2019.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328040/
https://www.ncbi.nlm.nih.gov/pubmed/30671214
http://dx.doi.org/10.4084/MJHID.2019.008

Ejemplares similares